Illicit Substance Exposure in Pregnancy and Infant Mortality Risk: A Nationwide Taiwan Study.

IF 4.5 2区 医学 Q1 CLINICAL NEUROLOGY
Chun Lin, Mu-Hong Chen, Wei-Szu Lin, Shiow-Ing Wu, Yuan-Chun Liao, Yu-Hsuan Lin, Ching-Heng Lin
{"title":"Illicit Substance Exposure in Pregnancy and Infant Mortality Risk: A Nationwide Taiwan Study.","authors":"Chun Lin, Mu-Hong Chen, Wei-Szu Lin, Shiow-Ing Wu, Yuan-Chun Liao, Yu-Hsuan Lin, Ching-Heng Lin","doi":"10.1093/ijnp/pyaf046","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To investigate the association between prenatal illicit substance exposure and infant mortality, addressing the unclear links between specific and multiple substances and increased mortality.</p><p><strong>Materials and methods: </strong>This 16-year retrospective cohort study used Taiwan's National Health Insurance Research Database, the Taiwan Maternal and Child Health dataset, and the Integrated Illegal Drug Database, including 1 937 301 pregnant women who delivered from 2004 to 2019. Among them, 11 477 used illicit drugs during pregnancy, with a matched control group of 45 908 non-users based on maternal age, income, and childbirth year. Of the drug users, 26.9% used multiple substances, primarily methamphetamine and opioids. The primary outcome was all-cause mortality within the first year of life, with analyses stratified by substance type and timing of exposure. Cox regression models were employed to assess mortality, with results presented as adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs). A p-value below 0.05 was considered statistically significant.</p><p><strong>Results: </strong>Infant from illicit drug-exposed mothers had a higher all-cause mortality rate (0.7%) compared to the control group (0.4%). Polysubstance use, which in most cases involved methamphetamine or opioids, was significantly associated with increased mortality risk (aHR 1.53, 95% CI 1.00-2.34), whereas no single substance alone-including methamphetamine (aHR 1.38, 95% CI 0.87-2.19) or opioids (aHR 1.63, 95% CI 0.98-2.72)-showed a statistically significant association. MDMA, ketamine, and cannabis were likewise not linked to increased mortality. Mortality risk increased with drug exposure during pregnancy, with borderline significant associations in the first (aHR 1.82, 95% CI 0.98-3.37) and second trimesters (aHR 1.96, 95% CI 0.99-3.86), suggesting heightened vulnerability during early to mid-gestation.</p><p><strong>Conclusion: </strong>One-year infant mortality is elevated among women with illicit substance use, with a higher proportion of deaths attributed to preterm birth and hypoxic events. The highest mortality risk was observed among those with polysubstance use. The findings underscore a dire public health issue, associating prenatal illicit substance exposure, notably multiple substances use, opioids, and methamphetamine, with heightened infant mortality rates, calling for targeted interventions and further research.</p>","PeriodicalId":14134,"journal":{"name":"International Journal of Neuropsychopharmacology","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Neuropsychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ijnp/pyaf046","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To investigate the association between prenatal illicit substance exposure and infant mortality, addressing the unclear links between specific and multiple substances and increased mortality.

Materials and methods: This 16-year retrospective cohort study used Taiwan's National Health Insurance Research Database, the Taiwan Maternal and Child Health dataset, and the Integrated Illegal Drug Database, including 1 937 301 pregnant women who delivered from 2004 to 2019. Among them, 11 477 used illicit drugs during pregnancy, with a matched control group of 45 908 non-users based on maternal age, income, and childbirth year. Of the drug users, 26.9% used multiple substances, primarily methamphetamine and opioids. The primary outcome was all-cause mortality within the first year of life, with analyses stratified by substance type and timing of exposure. Cox regression models were employed to assess mortality, with results presented as adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs). A p-value below 0.05 was considered statistically significant.

Results: Infant from illicit drug-exposed mothers had a higher all-cause mortality rate (0.7%) compared to the control group (0.4%). Polysubstance use, which in most cases involved methamphetamine or opioids, was significantly associated with increased mortality risk (aHR 1.53, 95% CI 1.00-2.34), whereas no single substance alone-including methamphetamine (aHR 1.38, 95% CI 0.87-2.19) or opioids (aHR 1.63, 95% CI 0.98-2.72)-showed a statistically significant association. MDMA, ketamine, and cannabis were likewise not linked to increased mortality. Mortality risk increased with drug exposure during pregnancy, with borderline significant associations in the first (aHR 1.82, 95% CI 0.98-3.37) and second trimesters (aHR 1.96, 95% CI 0.99-3.86), suggesting heightened vulnerability during early to mid-gestation.

Conclusion: One-year infant mortality is elevated among women with illicit substance use, with a higher proportion of deaths attributed to preterm birth and hypoxic events. The highest mortality risk was observed among those with polysubstance use. The findings underscore a dire public health issue, associating prenatal illicit substance exposure, notably multiple substances use, opioids, and methamphetamine, with heightened infant mortality rates, calling for targeted interventions and further research.

孕期接触违禁物质与婴儿死亡风险:一项台湾全国性研究。
背景:调查产前非法物质暴露与婴儿死亡率之间的关系,解决特定和多种物质与死亡率增加之间的不明确联系。材料与方法:本研究采用台湾全民健康保险研究数据库、台湾妇幼健康数据库和非法药物综合数据库,共16年回顾性队列研究,纳入2004 - 2019年分娩的1 937301例孕妇。其中,怀孕期间使用违禁药物的有11477人,根据产妇年龄、收入、分娩年份匹配的对照组为45 908人。在吸毒者中,26.9%使用多种物质,主要是甲基苯丙胺和阿片类药物。主要结果是生命第一年的全因死亡率,并根据物质类型和暴露时间进行分层分析。采用Cox回归模型评估死亡率,结果显示为校正风险比(aHRs), 95%置信区间(CIs)。p值小于0.05被认为具有统计学意义。结果:与对照组(0.4%)相比,非法药物暴露母亲所生婴儿的全因死亡率(0.7%)更高。多物质使用,在大多数情况下涉及甲基苯丙胺或阿片类药物,与死亡风险增加显著相关(aHR 1.53, 95% CI 1.00-2.34),而没有单一物质-包括甲基苯丙胺(aHR 1.38, 95% CI 0.87-2.19)或阿片类药物(aHR 1.63, 95% CI 0.98-2.72)-显示出统计学上显著的关联。MDMA、氯胺酮和大麻同样与死亡率增加无关。妊娠期间药物暴露增加了死亡风险,在妊娠早期(aHR 1.82, 95% CI 0.98-3.37)和妊娠中期(aHR 1.96, 95% CI 0.99-3.86)具有显著的临界相关性,表明妊娠早期至中期的易感性增加。结论:在使用非法药物的妇女中,一岁婴儿死亡率升高,早产和缺氧事件导致的死亡比例较高。在使用多种药物的人群中观察到最高的死亡风险。调查结果强调了一个可怕的公共卫生问题,将产前接触非法物质,特别是多种物质的使用、阿片类药物和甲基苯丙胺与婴儿死亡率升高联系起来,呼吁采取有针对性的干预措施和进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.40
自引率
2.10%
发文量
230
审稿时长
4-8 weeks
期刊介绍: The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology and neuropsychology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信